FFA
TYRA icon

Farther Finance Advisors’s Tyra Biosciences TYRA Stock Holding History

Farther Finance Advisors’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.64K Buy
75
+15
+25% +$412 ﹤0.01% 5455
2026
Q2 		$1.92K Hold
60
– – ﹤0.01% 5182
2026
Q1 		$2.3K Hold
60
– – ﹤0.01% 4848
2025
Q4 		$1.58K Buy
60
+49
+445% +$900 ﹤0.01% 4778
2025
Q3 		$154 Buy
+11
New +$125 ﹤0.01% 4775

Other funds holding TYRA

VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors's TYRA Position: Q3 2026 in Review

Farther Finance Advisors increased its Tyra Biosciences (TYRA) stake by 25% in Q3 2026, buying an estimated $412 and bringing the position to 75 shares worth $1.64K. The position accounts for ﹤0.01% of the portfolio, ranked #5455.

Farther Finance Advisors first reported a position in TYRA in Q3 2025 and has held it in 5 quarters since. The position peaked at $2.3K in Q1 2026. 3 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.

  • Farther Finance Advisors held 75 shares of Tyra Biosciences worth $1.64K as of Q3 2026.
  • Farther Finance Advisors bought 15 Tyra Biosciences shares in Q3 2026, an estimated $412.
  • Tyra Biosciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5455 holding.
  • Farther Finance Advisors first reported a position in Tyra Biosciences in Q3 2025 and has held it in 5 quarters since.
  • Farther Finance Advisors's Tyra Biosciences position peaked at $2.3K in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.